The University of Oxford's Gene Medicine Research Group, based at the John Radcliffe Hospital, seeks a Post-Doctoral Research Scientist to develop lentiviral-derived nanoparticles for treating rare diseases, optimizing production, purification, and concentration processes.
Text as published by the employer. Always confirm details on the employer's site.